BioSpace News Archive

In addition to earning CME credits for literature searches, busy healthcare professionals (HCPs) can now also acquire credits through mobile learning courses in a matter of minutes each day.

These additions come as Fractyl is preparing for commercialization efforts outside the U.S. and has started the company’s first U.S. clinical trial for its lead product candidate Revita™ DMR for the treatment of type 2 diabetes and fatty liver disease.

Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials

Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, reported financial results for the fourth quarter and year ended December 31, 2018 and provided a corporate update.

Lifestyle Delivery Systems Inc. announces that its subsidiary, CSPA Group, Inc., has delivered its second large batch of Rêveur live resin to Rise Distribution.

Distribution in Europe, Middle East, India and Africa for the treatment of tendinopathy

Array BioPharma Inc. announced that the National Comprehensive Cancer Network® has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to include BRAFTOVI® in combination with MEKTOVI® and an anti-EGFR antibody as a Category 2a treatment for patients with BRAFV600E-mutant metastatic colorectal cancer, after failure of one or two prior lines of therapy for metastatic disease.

Ms. Casner will serve on the Executive Leadership Team and report to George Fotiades, President and CEO.

Panel addresses how clinical trial sites can leverage technology to increase efficiency and effectiveness for bottom-line results

Boston Heart Diagnostics announced the publication of a new research study: “Cardiovascular Risk Factor Reduction in First Responders Resulting from and Individualized Lifestyle and Blood Test Program: A Randomized Controlled Trial”.